A Committed Team

Our Leadership

We are dedicated to applying our greater understanding of the NLRP3 inflammasome and its role in driving disease to develop industry leading inhibitors. Helping patients is our primary motivation and we are fortunate 
to be in a position to use our combined expertise and many years of industry experience to develop ground-breaking medicines to combat many 
debilitating diseases.


Board of Directors

Scientific Advisory Board

Senior Advisors

Our Investors

We are proud to be working with a number of partners and investors who share and respect our vision.

Follow our Progress & Insights

Inflazome is making rapid progress in advancing our clinical and preclinical assets. Keep up with the latest news on Inflazome’s research and development activities with regular email updates.

Speak to us about
a better tomorrow

Contact Us